Tradestie Institutional Equity Comparison Engine

SRRK vs ELVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ELVN Overall Edge

ELVN Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Enliven Therapeutics, Inc. Common Stock (ELVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SRRK trades at N/M Forward P/E with -71732.3% operating margin (-100.0% YoY revenue) versus ELVN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SRRK sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro) against ELVN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SRRK N/M vs ELVN N/M Fwd P/E
Growth & Margin Winner ELVN
Op Margin -71732.3% vs 0.0% ยท YoY -100.0% vs +0.0%
Momentum & Technical Winner ELVN
1Y +43.7% vs +134.5% ยท 52W Pos 43% vs 69%
Options & Structure Winner ELVN
BREAKDOWN (7th %ile IV) vs CONSOLIDATION (5th %ile IV)
SRRK NASDAQ
Scholar Rock Holding Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$43.21
+0.01% 1D
Market Cap $5.3B
1M Return +8.3%
1Y Return +43.7%
Forward P/E N/M
Unified AI Score
55.1 / 100 HOLD
Tech 49.0 Fund 57.0 Flow 64.0 Mom 60.0
ELVN NASDAQ
Enliven Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$47.54
-2.58% 1D
Market Cap $3.6B
1M Return +27.38%
1Y Return +134.53%
Forward P/E N/M
Unified AI Score
36.2 / 100 SELL
Tech 15.0 Fund 44.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SRRK +43.7% ELVN +134.53% Spread: +90.83 pp (ELVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SRRK TTM Op. Margin: -71732.3% ELVN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SRRK vs ELVN. Trailing 12-month operating profitability (SRRK -71732.3% vs ELVN 0.0%) and valuation multiples (SRRK N/M vs ELVN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SRRK (2) vs ELVN (5)
Institutional Metric SRRK ELVN Criterion Row Winner
Market Capitalization Scale $5.3B $3.6B Larger Scale SRRK
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% +0.0% Higher Growth ELVN
Operating Margin (TTM) Profitability -71732.3% 0.0% Higher Margin ELVN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -200.0% -16.8% Higher ROE ELVN
52-Week Range Position Momentum 43% ($29โ€“$62) 69% ($15โ€“$62) Stronger Trend ELVN
Beta / 30D Volatility Risk Regime 1.02ฮฒ ยท 61% Vol 0.96ฮฒ ยท 60% Vol Lower Realized Risk ELVN
Unified Institutional Score Composite Signal 55.1 / 100 (HOLD) 36.2 / 100 (SELL) Higher Composite SRRK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SRRK vs ELVN Buy Guide
SRRK BREAKDOWN
57d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live SRRK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ELVN CONSOLIDATION
59d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live ELVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SRRK nor ELVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.